Annual report 2021

Patents

The Fraunhofer IZI patent portfolio currently consists of 56 patent families (excluding patents held at Fraunhofer IZI-BB), which are available for use in collaborative projects as well as for direct marketing and licensing.

• Technologies for the generation of pluripotent stem cells 
• Methods for the diagnosis of infectious agents 
• Methods for the diagnosis of cancer 
• New treatment methods for cancer and other diseases 
• New method for the prevention of graft-versus-host disease (GvHD) 
• Method for immobilization of cells on surfaces 
• Mineral compounds for prevention / therapy of kidney and intestinal diseases 
• Method for the preparation of a leukocyte preparation 
• Biomarkers and diagnostic systems for human or veterinary application 
• RNA species for therapeutic and / or diagnostic use 
• Methods and devices for point-of-care diagnostics 
• Agents for the therapy of infectious as well as fibrotic and neurodegenerative diseases 
• Methods for immunomodulation and treatment of immunological diseases 
• Surface modification 
• Inactivation of pathogens in the context of vaccine production and novel vaccine candidates 
• Methods for transferring nucleic acids into cells 
• Epitopes from food relevant for the development of allergies and methods for allergen extraction 
• Methods for the transplantation of microbiomes 
• Components of microscopic systems, especially light sheet microscopy 
• Dialysis methods and novel components of dialysis systems 
• Novel AAV vectors 
• Method for improved image analysis